NK cells and T cells cooperate during the clinical course of colorectal cancer

References

• McLean MH, Murray GI, Stewart KN, Norrie G, Mayer C, Hold GL, Thomson J, Fyfe N, Hope M, Mowat NAG, et al. The inflammatory microenvironment in colorectal neoplasia. PLoS One 2011; 6:e15366; PMID:21249124; http://dx.doi.org/10.1371/journal.pone.0015366
   PubMed Web of Science ®Google Scholar
• Algars A, Irjala H, Vaittinen S, Huhtinen H, Sundstrom J, Salmi M, Ristamaki R, Jalkanen S. Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Int J Cancer 2012; 131:864-73; PMID:21952788; http://dx.doi.org/10.1002/ijc.26457
   PubMed Web of Science ®Google Scholar
• Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin.Cancer Res 2007; 13:1472-9; PMID:17332291
   PubMed Web of Science ®Google Scholar
• Sconocchia G, Zlobec I, Lugli A, Calabrese D, Iezzi G, Karamitopoulou E, Patsouris ES, Peros G, Horcic M, Tornillo L, et al. Tumor infiltration by FcgammaRIII (CD16) +myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int J Cancer 2011; 128:2663-72; PMID:20715106; http://dx.doi.org/10.1002/ijc.25609
   PubMed Web of Science ®Google Scholar
• Droeser RA, Hirt C, Eppenberger-Castori S, Zlobec I, Viehl CT, Frey DM, Nebiker CA, Rosso R, Zuber M, Amicarella F, et al. High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS One 2013; 8:e64814; PMID:23734221; http://dx.doi.org/10.1371/journal.pone.0064814
   PubMed Web of Science ®Google Scholar
• Hirt C, Eppenberger-Castori S, Sconocchia G, Iezzi G, Tornillo L, Terracciano L, Spagnoli GC, Droeser R. Colorectal cancer infiltration by myeloperoxidase positive neutrophil granulocytes is associated with favorable prognosis. Oncoimmunology 2013; 2:e25990; PMID:24244897; http://dx.doi.org/10.4161/onci.25990
   PubMedGoogle Scholar
• Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353:2654-66; http://dx.doi.org/10.1056/NEJMoa051424
   PubMed Web of Science ®Google Scholar
• Frey DM, Droeser RA, Viehl CT, Zlobec I, Lugli A, Zingg U, Oertli D, Kettelhack C, Terracciano L, Tornillo L. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer 2010; 126:2635-43; PMID:19856313
   PubMed Web of Science ®Google Scholar
• Desbois M, Rusakiewicz S, Locher C, Zitvogel L, Chaput N. Natural killer cells in non-hematopoieticmalignancies. Front Immunol 2012; 3:395; PMID:23269924; http://dx.doi.org/10.3389/fimmu.2012.00395
   PubMedGoogle Scholar
• Savani BN, Rezvani K, Mielke S, Montero A, Kurlander R, Carter CS, Leitman S, Read EJ, Childs R, Barrett AJ. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood 2006; 107:1688-95; PMID:16131570; http://dx.doi.org/10.1182/blood-2005-05-1897
   PubMed Web of Science ®Google Scholar
• Savani BN, Mielke S, Adams S, Uribe M, Rezvani K, Yong AS, Zeilah J, Kurlander R, Srinivasan R, Childs R, et al. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia. Leukemia 2007; 21:2145-52; PMID:17673900; http://dx.doi.org/10.1038/sj.leu.2404892
   PubMed Web of Science ®Google Scholar
• Gulubova M, Manolova I, Kyurkchiev D, Julianov A, Altunkova I. Decrease in intrahepatic CD56 +lymphocytes in gastric and colorectal cancer patients with liver metastases. APMIS 2009; 117:870-9; PMID:20078551; http://dx.doi.org/10.1111/j.1600-0463.2009.02547.x
   PubMed Web of Science ®Google Scholar
• Marechal R, De SJ, Nagy N, Demetter P, Lemmers A, Deviere J, Salmon I, Tejpar S, Van Laethem JL. Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients. BMC Cancer 2010; 10:340; PMID:20591136; http://dx.doi.org/10.1186/1471-2407-10-340
   PubMed Web of Science ®Google Scholar
• Menon AG, Janssen-van Rhijn CM, Morreau H, Putter H, Tollenaar RA, van de Velde CJ, Fleuren GJ, Kuppen PJ. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab Invest 2004; 84:493-501; PMID:14968119
   PubMed Web of Science ®Google Scholar
• Sandel MH, Speetjens FM, Menon AG, Albertsson PA, Basse PH, Hokland M, Nagelkerke JF, Tollenaar RA, van de Velde CJ, Kuppen PJ. Natural killer cells infiltrating colorectal cancer and MHC class I expression. Mol Immunol 2005; 42:541-6.
   PubMed Web of Science ®Google Scholar
• Halama N, Braun M, Kahlert C, Spille A, Quack C, Rahbari N, Koch M, Weitz J, Kloor M, Zoernig I, et al. Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines. Clin Cancer Res 2011; 17:678-89.
   PubMed Web of Science ®Google Scholar
• Sconocchia G, Spagnoli GC, Del Principe D, Ferrone S, Anselmi M, Wongsena W, Cervelli V, Schultz-Thater E, Wyler S, Carafa V, et al. Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction. Neoplasia 2009; 11:662-71; PMID:19568411
   PubMed Web of Science ®Google Scholar
• Sconocchia G, Arriga R, Tornillo L, Terracciano L, Ferrone S, Spagnoli GC. Melanoma cells inhibit NK cell functions–letter. Cancer Res 2012; 72:5428-9; PMID:23047870; http://dx.doi.org/10.1158/0008-5472.CAN-12-1181
   PubMed Web of Science ®Google Scholar
• Shanker A, Verdeil G, Buferne M, Inderberg-Suso EM, Puthier D, Joly F, Nguyen C, Leserman L, Auphan-Anezin N, Schmitt-Verhulst AM. CD8 T cell help for innate antitumor immunity. J Immunol 2007; 179:6651-62; http://dx.doi.org/10.4049/jimmunol.179.10.6651
   PubMed Web of Science ®Google Scholar
• Srivastava RM, Lee SC, Andrade Filho PA, Lord CA, Jie HB, Davidson C, Lopez-Albaitero A, Gibson SP, Gooding WE, Ferrone S, et al. Cetuximab-activated natural killer (NK) and dendritic cells (DC) collaborate to trigger tumor antigen-specific T cell immunity in head and neck cancer patients. Clin. Cancer Res 2013; 19:1858-72; PMID:23444227; http://dx.doi.org/10.1158/1078-0432.CCR-12-2426
   PubMed Web of Science ®Google Scholar
• Grzywacz B, Kataria N, Verneris MR. CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases. Leukemia 2007; 21:356-9; PMID:17251901; http://dx.doi.org/10.1038/sj.leu.2404499
   PubMed Web of Science ®Google Scholar
• Harrison D, Phillips JH, Lanier LL. Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gamma RIII (CD16-II). J Immunol 1991; 147:3459-65; PMID:8558016
   PubMed Web of Science ®Google Scholar
• Jewett A, Bonavida B. Target-induced inactivation and cell death by apoptosis in a subset of human NK cells. J Immunol 1996; 156:907-15; PMID:8558016
   PubMed Web of Science ®Google Scholar
• Ortaldo JR, Mason AT, O'Shea JJ. Receptor-induced death in human natural killer cells: involvement of CD16. J Exp Med 1995; 181:339-44; PMID:7528771; http://dx.doi.org/10.1084/jem.181.1.339
   PubMed Web of Science ®Google Scholar
• Pietra G, Vitale M, Manzini C, Balsamo M, Moretta L, Mingari MC. Melanoma cells inhibit NK cell functions–response. Cancer Res 2012; 72:5430; http://dx.doi.org/10.1158/0008-5472.CAN-12-2526
   Web of Science ®Google Scholar
• Pietra G, Manzini C, Rivara S, Vitale M, Cantoni, Petretto A, Balsamo M, Conte R, Benelli R, Minghelli S, et al. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res 2012; 72:1407-15; PMID:22258454; http://dx.doi.org/10.1158/0008-5472.CAN-11-2544
   PubMed Web of Science ®Google Scholar
• Poggi A, Massaro AM, Negrini S, Contini P, Zocchi MR. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors. J Immunol 2005; 174:2653-60; PMID:15728472; http://dx.doi.org/10.4049/jimmunol.174.5.2653
   PubMed Web of Science ®Google Scholar
• Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, Goncalves A, Andre P, Romagne F, Thibault G, et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest 2011; 121:3609-22; PMID:21841316; http://dx.doi.org/10.1172/JCI45816
   PubMed Web of Science ®Google Scholar
• Sconocchia G, Fujiwara H, Rezvani K, Keyvanfar K, El Ouriaghli F. Grube M, Melenhorst J, Barrett AJ. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotipically novel monocyte. J Leuk Biol 2004; 76:1214-9; http://dx.doi.org/10.1189/jlb.0504278
   PubMed Web of Science ®Google Scholar
• Raspadori D, Damiani D, Lenoci M, Rondelli D, Testoni N, Nardi G, Sestigiani C, Mariotti C, Birtolo S, Tozzi M, et al. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia 2001; 15:1161-4; PMID:11480556; http://dx.doi.org/10.1038/sj.leu.2402174
   PubMed Web of Science ®Google Scholar
• Zecchini S, Bombardelli L, Decio A, Bianchi M, Mazzarol G, Sanguinetti F, Aletti G, Maddaluno L, Berenzin V, Bock E, et al. The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signaling. EMBO Mol Med 2011; 3:480-94; PMID:21739604; http://dx.doi.org/10.1002/emmm.201100152
   PubMed Web of Science ®Google Scholar
• Cavallaro U, Niedermeyer J, Fuxa M, Christofori G. N-CAM modulates tumor-cell adhesion to matrix by inducing FGF-receptor signaling. Nat Cell Biol 2001; 3:650-57; PMID:11433297; http://dx.doi.org/10.1038/35083041
   PubMed Web of Science ®Google Scholar
• Cirovic S, Vjestica J, Mueller CA, Tatic S, Vasiljevic J, Milenkovic S, Mueller GA, Markovic-Lipkovski J. NCAM and FGFR1 coexpression and colocalization in renal tumors. Int J Clin Exp Pathol 2014; 7:1402-14; PMID:24817936
   PubMedGoogle Scholar